Status:
COMPLETED
Financial Incentives to Improve Asthma
Lead Sponsor:
Imperial College London
Conditions:
Asthma in Children
Medication Adherence
Eligibility:
All Genders
11-17 years
Phase:
NA
Brief Summary
The aim of this pilot randomised controlled trial is to assess the effectiveness of a short-term financial incentives intervention at bringing about behaviour change, namely short-medium term improvem...
Detailed Description
After obtaining informed consent from parents (and assent from the CYP), CYP will be enrolled in a 24-week programme. All participants will receive an electronic monitoring device (EMD) which will be ...
Eligibility Criteria
Inclusion
- Informed consent obtained from parent/guardian and assent from child.
- CYP with doctor diagnosed asthma presenting to Emergency Department (ED) with a severe asthma exacerbation (as defined by ERS/ATS guidelines).
- Aged between 11 and 17 years old
- Prescribed maintenance inhaled corticosteroids (ICS) (which can include maintenance and reliever therapy MART) for at least 6-months.
- Own their own mobile smartphone (running Android 8 or higher, or iOS 13 or higher)
- Prescribed the following inhalers: Clenil, Flixotide, Symbicort, Seretide
Exclusion
- Parent/guardian / CYP unable to provide consent / assent
- CYP with other, co-existing respiratory conditions
- Parent/guardian/CYP who are not fluent or able to understand the information provided in English.
- CYP who are involved in other intervention research studies (including CTIMPs)
Key Trial Info
Start Date :
July 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2023
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05322044
Start Date
July 18 2022
End Date
September 28 2023
Last Update
February 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Mary's Hospital
London, United Kingdom, W2 1NY